SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Inaccuracies Revealed In Studies Of Cancer Treatment
April 23, 2008
 · 
1 min read
Drug Development
Chemotherapy Drug Cisplatin Fails To Improve Disease-free Survival; Results In More Colostomies, University of Texas M. D. Anderson Cancer Center Study
April 23, 2008
 · 
1 min read
Lone Star Bio
Stomach-Proof Gel Hints At Jab-Free Diabetes Treatment
April 22, 2008
 · 
1 min read
Lone Star Bio
Worm-On-A-Chip Boosts Understanding Of Nerves
April 22, 2008
 · 
1 min read
Biotech Bay
U.S. Identifies Tainted Heparin in 11 Countries
April 22, 2008
 · 
1 min read
Lone Star Bio
New Technologies Offer More Accurate Means Of Diagnosis And Monitoring Cancer
April 21, 2008
 · 
1 min read
Lone Star Bio
Treatment Bias Can Skew Results of Observational Studies, University of Texas M. D. Anderson Cancer Center
April 21, 2008
 · 
1 min read
Drug Development
New Type Of Drug Shrinks Primary Breast Cancer Tumors Significantly In Just 6 Weeks, Baylor College of Medicine Study Shows
April 17, 2008
 · 
1 min read
Lone Star Bio
Saliva Can Help Diagnose Heart Attack, University of Texas Study Shows
April 17, 2008
 · 
1 min read
Lone Star Bio
Mouth Swab May One Day Diagnose Lung Cancer, M. D. Anderson Cancer Center Study
April 17, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Load More